Plain-English translation of NCT07029126 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →This study is looking at how — a newer preventive migraine medication — affects not just patients, but also the people who care for them at home. Researchers want to understand whether this medication reduces the emotional burden on caregivers and helps strengthen the relationship between patients and their caregivers over six months of treatment.
Migraines can be incredibly stressful not only for patients but also for family members and partners who support them. Researchers want to know whether treating migraines more effectively with this medication can ease the emotional toll on caregivers and bring couples closer together.
You likely qualify if…
You likely don't qualify if…
Both you and your caregiver would join the study together. You would start the new migraine medication () as prescribed by your doctor, and over six months, you and your caregiver would complete short questionnaires and keep a diary about how you're feeling, your migraines, and how your relationship is doing. The study follows real life—you're not changing your normal routine, just tracking and sharing information with researchers.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Italy